BioXcel Therapeutics Inc (NASDAQ:BTAI)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - BTAI
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - BTAI
- Market Cap$1.174bn
- SymbolNASDAQ:BTAI
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS09075P1057
Company Profile
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Latest BTAI news
Currently there for this company. Visit our news hub for other news .